| Mar'20 | Mar'19 | |||||
|---|---|---|---|---|---|---|
Costs and operating expenses: | ||||||
Research and development | ||||||
0 | 0 | |||||
Selling, general and administrative | ||||||
0 | 0 | |||||
Total costs and operating expenses | ||||||
0 | 0 | |||||
Loss from operations | ||||||
0 | 0 | |||||
Other income (expense): | ||||||
Interest income | ||||||
0 | 0 | |||||
Interest expense | ||||||
0 | - | |||||
Other income (expense), net | ||||||
0 | 0 | |||||
Total other income (expense), net | ||||||
0 | 0 | |||||
Net loss before income tax | ||||||
0 | 0 | |||||
Income tax (expense) benefit | ||||||
0 | 0 | |||||
Net loss attributable to ordinary shareholders | ||||||
0 | 0 | |||||
Other comprehensive income (loss): | ||||||
Foreign currency translation adjustment | ||||||
0 | 0 | |||||
Unrealized loss on marketable securities | ||||||
0 | - | |||||
Total other comprehensive income (loss): | ||||||
0 | 0 | |||||
Total comprehensive loss | ||||||
0 | 0 | |||||
Net loss per share attributable to ordinary shareholders, basic and diluted | ||||||
-0.51 | -0.35 | |||||
Weighted average number of ordinary shares outstanding, basic and diluted | ||||||
98,713,126 | 87,010,596 | |||||